Your email has been successfully added to our mailing list.

×
-0.37979094076655 -0.365156794425087 -0.317073170731707 -0.303135888501742 -0.306620209059233 -0.281533101045296 -0.285714285714286 -0.259233449477352
Stock impact report

Achaogen Announces FDA Advisory Committee Voted Unanimously in Favor of Plazomicin for Treatment of Adults with Complicated Urinary Tract Infections

ACHAOGEN (AKAO) 
Last achaogen earnings: 3/28 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.achaogen.com/investor-overview
Company Research Source: GlobeNewswire
SOUTH SAN FRANCISCO, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today announced that the U.S. Food and Drug Administration's (FDA) Antimicrobial Drugs Advisory Committee voted on the two points for Advisory Committee consideration as follows: 1. Has the applicant provided substantial evidence of the safety and effectiveness of plazomicin for the treatment of complicated urinary tract infections? Result: (15-0-0) There were 15 yes votes and zero no votes. No members of the panel abstained. 2. Has the applicant provided substantial evidence of the safety and effectiveness of plazomicin for the treatment of bloodstream infections in patients with limited or no treatment options? Result: (4-11-0) There were four yes votes and 11 no votes. No members of the panel abstained. There were 16 panel members at the Show less Read more
Impact Snapshot
Event Time:
AKAO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AKAO alerts
Opt-in for
AKAO alerts

from News Quantified
Opt-in for
AKAO alerts

from News Quantified